Sentences with phrase «of adjuvant technology»
Not exact matches
This review article appearing in Technology and submitted by researchers from Iowa State University investigates the potential of polymeric adjuvants, both natural and synthetic.
https://www.sciencedaily.com/
The department features expertise, technology and infrastructure in the fields of adjuvants, immune modulators and formulation, including mucosal adjuvants.
Technology transfer of methods, protocols, and procedures for the preparation and QC of adjuvants
Today UNIL - VFL provides access to adjuvants, adjuvant quality control technology, adjuvant formulation expertise, technology transfer, training, and bespoke adjuvant R&D services, allowing partners to gain optimal benefit from the use of adjuvants and vaccine formulation technology.
The HZI will provide expertise and technologies for adjuvants and the preclinical validation of vaccine technologies and candidates in murine systems.
We will consider near - infrared, confocal endomicroscopy (two - colour CellVizio technology), two - photon microscopy, single photon emission tomography (SPECT) and positron emission tomography (PET) scan platforms available from CEA, HZI and INRA, and will develop new tracers to tag antigens, adjuvants, particles / vehicles and vectors for the in vivo visualisation of dissemination and biodistribution.
The LPS adjuvant platform technology of Intravacc is open for new collaborations, which can range from out - licensing to large collaborative development, process optimization and cGMP production.
The other two pandemic influenza projects focus on the efficacy of recombinant protein and VLP pandemic influenza vaccines combined with IDRI's adjuvant technology.
Important reports from the Weiner lab include the first DNA vaccine studied for HIV as well as for cancer immune therapy of cutaneous T cell lymphoma, the early development of DNA encoded genetic adjuvants, including IL - 12, advances in gene optimization, and advances in electroporation technologies resulting in improved gene delivery.
Moving the Needle provides quarterly updates from PATH's Center for Vaccine Innovation and Access (CVIA) on our vaccine development efforts, as well as related supporting work, such as developing human challenge models, building capacity of developing - country vaccine manufacturers, and evaluating new adjuvants and other novel vaccine technologies.
The department features expertise, technology and infrastructure in the fields of adjuvants and formulation, including mucosal adjuvants.